Literature DB >> 2553776

Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease.

D H Perlmutter1, M J Schlesinger, J A Pierce, P I Punsal, A L Schwartz.   

Abstract

Individuals who are homozygous for the protease inhibitor phenotype Z (PiZ) genetic variant of alpha 1-antitrypsin (alpha 1-AT) have reduced plasma concentrations of alpha 1-AT, and are susceptible to premature development of pulmonary emphysema. A subset of this population develops chronic liver disease. The reduction in plasma concentrations of alpha 1-AT results from a selective defect in secretion as the abnormal PiZ alpha 1-AT protein accumulates within the cell. It has recently been shown in several experimental systems that the heat shock/stress response, a response characterized by the synthesis of a family of highly evolutionarily conserved proteins during thermal or chemical stress, may also be activated by the presence of abnormal proteins within the cell. Therefore, we predicted that the heat shock/stress response would be induced in the absence of thermal or chemical stress in alpha 1-AT-synthesizing cells of PiZZ individuals. In the following study, however, we show that net synthesis of proteins in the heat shock/stress gene family (SP90, SP70, ubiquitin) is increased only in a subset of the population, PiZZ individuals with liver disease. It is not significantly increased in PiZZ individuals with emphysema or in those without apparent tissue injury. Net synthesis of stress proteins is not increased in individuals with another variant of the alpha 1-AT gene (PiS alpha 1-AT) and is not increased in individuals with severe liver disease but a normal alpha 1-AT haplotype (PiM alpha 1-AT). These results demonstrate that the synthesis of stress proteins is increased in a subset of individuals with homozygous PiZZ alpha 1-AT deficiency, those also having liver disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553776      PMCID: PMC304021          DOI: 10.1172/JCI114332

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency.

Authors:  A Yoshida; J Lieberman; L Gaidulis; C Ewing
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

2.  Amino acid substitution Glu leads to Lys alpha1-antitrypsin PiZ.

Authors:  J O Jeppsson
Journal:  FEBS Lett       Date:  1976-06-01       Impact factor: 4.124

3.  alpha-1-Antitrypsin: sequence of the Z variant tryptic peptide.

Authors:  M C Owen; R W Carrell
Journal:  FEBS Lett       Date:  1977-07-15       Impact factor: 4.124

4.  Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.

Authors:  J A Carlson; B B Rogers; R N Sifers; M J Finegold; S M Clift; F J DeMayo; D W Bullock; S L Woo
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

5.  Hepatocyte ultrastructural changes in alpha1-antitrypsin deficiency.

Authors:  G Feldmann; J Bignon; P Chahinian; C Degott; J P Benhamou
Journal:  Gastroenterology       Date:  1974-12       Impact factor: 22.682

6.  Efficient translation of tobacco mosaic virus RNA and rabbit globin 9S RNA in a cell-free system from commercial wheat germ.

Authors:  B E Roberts; B M Paterson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

7.  The effect of amino acid analogues and heat shock on gene expression in chicken embryo fibroblasts.

Authors:  P M Kelley; M J Schlesinger
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

8.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants.

Authors:  T Sveger
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

9.  Disruption of the 290-342 salt bridge is not responsible for the secretory defect of the PiZ alpha 1-antitrypsin variant.

Authors:  R N Sifers; C P Hardick; S L Woo
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  9 in total

Review 1.  Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

Authors:  R G Crystal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

2.  α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8.

Authors:  David A Bergin; Emer P Reeves; Paula Meleady; Michael Henry; Oliver J McElvaney; Tomás P Carroll; Claire Condron; Sanjay H Chotirmall; Martin Clynes; Shane J O'Neill; Noel G McElvaney
Journal:  J Clin Invest       Date:  2010-11-08       Impact factor: 14.808

Review 3.  Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history.

Authors:  M Needham; R A Stockley
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

4.  A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency.

Authors:  Y Wu; I Whitman; E Molmenti; K Moore; P Hippenmeyer; D H Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  Stress-induced heat shock protein 70 expression in adrenal cortex: an adrenocorticotropic hormone-sensitive, age-dependent response.

Authors:  M J Blake; R Udelsman; G J Feulner; D D Norton; N J Holbrook
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele.

Authors:  J P Faber; W Poller; S Weidinger; M Kirchgesser; R Schwaab; F Bidlingmaier; K Olek
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

Review 7.  Alpha 1-antitrypsin deficiency and liver disease: clinical presentation, diagnosis and treatment.

Authors:  M Hussain; G Mieli-Vergani; A P Mowat
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 8.  Alpha 1-antitrypsin deficiency and liver disease.

Authors:  P Birrer; N G McElvaney; L M Chang-Stroman; R G Crystal
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 9.  Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus.

Authors:  Sangmi S Park; Romy Rodriguez Ortega; Christina W Agudelo; Jessica Perez Perez; Brais Perez Gandara; Itsaso Garcia-Arcos; Cormac McCarthy; Patrick Geraghty
Journal:  Medicina (Kaunas)       Date:  2021-04-20       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.